Literature DB >> 24234572

The mass spectrometry of taxol.

T D McClure1, K H Schram, M L Reimer.   

Abstract

The antitumor agent taxol has been examined by electron ionization, chemical ionization, and fast atom bombardment mass spectrometry. Three ion series are observed: (1) the M-series, characteristic of the intact molecule; (2) the T-series, with fragments derived from the taxane ring; and (3) the S-series representing the C-13 side chain. Neutral losses dominate each series of ions and serve to verify the presence and number of functionalities in each portion of the molecule. Fragmentation pathways and mechanisms of ion formation are proposed on the basis of product ion analysis and accurate mass measurements.

Entities:  

Year:  1992        PMID: 24234572     DOI: 10.1016/1044-0305(92)85009-9

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  8 in total

1.  Fast atom bombardment mass spectrometry of bouvardin and selected analogs.

Authors:  D L Slowikowski; K H Schram
Journal:  Biomed Mass Spectrom       Date:  1985-02

2.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.

Authors:  M C Wani; H L Taylor; M E Wall; P Coggon; A T McPhail
Journal:  J Am Chem Soc       Date:  1971-05-05       Impact factor: 15.419

3.  Deuterium-labeled 3-nitrobenzyl alcohol as a matrix for fast atom bombardment mass spectrometry.

Authors:  A M Reddy; V V Mykytyn; K H Schram
Journal:  Biomed Environ Mass Spectrom       Date:  1989-12

4.  Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.

Authors:  W P McGuire; E K Rowinsky; N B Rosenshein; F C Grumbine; D S Ettinger; D K Armstrong; R C Donehower
Journal:  Ann Intern Med       Date:  1989-08-15       Impact factor: 25.391

5.  Taxol and derivatives: a biogenetic hypothesis.

Authors:  F Guéritte-Voegelein; D Guénard; P Potier
Journal:  J Nat Prod       Date:  1987 Jan-Feb       Impact factor: 4.050

6.  Phase I trial of taxol in patients with advanced cancer.

Authors:  R C Donehower; E K Rowinsky; L B Grochow; S M Longnecker; D S Ettinger
Journal:  Cancer Treat Rep       Date:  1987-12

7.  Phase I study of taxol administered as a short i.v. infusion daily for 5 days.

Authors:  J L Grem; K D Tutsch; K J Simon; D B Alberti; J K Willson; D C Tormey; S Swaminathan; D L Trump
Journal:  Cancer Treat Rep       Date:  1987-12

8.  High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial.

Authors:  S M Longnecker; R C Donehower; A E Cates; T L Chen; R B Brundrett; L B Grochow; D S Ettinger; M Colvin
Journal:  Cancer Treat Rep       Date:  1987-01
  8 in total
  2 in total

1.  Isolation and identification of an anticancer drug, taxol from Phyllosticta tabernaemontanae, a leaf spot fungus of an angiosperm, Wrightia tinctoria.

Authors:  Rangarajulu Senthil Kumaran; Johnpaul Muthumary; Byung-Ki Hur
Journal:  J Microbiol       Date:  2009-02-20       Impact factor: 3.422

2.  Isolation of taxol producing endophytic fungus Alternaria brassicicola from non-Taxus medicinal plant Terminalia arjuna.

Authors:  Harman Gill; M Vasundhara
Journal:  World J Microbiol Biotechnol       Date:  2019-05-03       Impact factor: 3.312

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.